Surmodics, Inc. announced new real-world results from the PROWL registry evaluating the company’s Pounce thrombectomy pl ...

Peripheral artery disease, or PAD, is a condition where the arteries become narrow or blocked over time, most often affecting ...

Vascular. 2005;13(2):84-91. The most common causes of injury in the present series were lacerations from either accidental, occupational, or road traffic injuries. Stab injuries and missile injuries ...

Aug. 9, 2002 -- Injecting autologous bone marrow into the gastrocnemius of patients with ischemic limbs can significantly improve blood flow, tissue oxygenation, and symptoms, according to results of ...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care ...

Blacks with critical limb ischemia are disproportionately more likely to undergo limb amputation, according to a report presented at the Vascular Annual Meeting. Researchers from the Howard University ...

In patients with critical limb ischemia (CLI) and no good therapeutic options, treatment with autologous stem cells appears safe and may help stave off amputation, according to data from a small ...

DUBLIN--(BUSINESS WIRE)--The "Critical Limb Ischemia - Pipeline Review, H2 2017" report has been added to Research and Markets' offering. Critical Limb Ischemia - Pipeline Review, H2 2017, provides ...

Critical Limb Ischemia companies are Boston Scientific Corporation, AnGes, Inc., Mitsubishi Tanabe Pharma, B. Braun Melsungen AG, Medtronic Endovascular, Ixaka Ltd ...

Critical Limb Ischemia companies are Boston Scientific Corporation, AnGes, Inc., Mitsubishi Tanabe Pharma, B. Braun Melsungen AG, Medtronic Endovascular, Ixaka Ltd ...

According to Coherent Market Insights (CMI), the global critical limb ischemia market size is projected to expand at a CAGR of 8.8%, growing from USD 5.55 Bn in 2025 to USD 10.02 Bn by 2032. Based on ...